The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: A double-blind placebo-controlled study

Clinical Physiology

Volumn 17, Issue 5, 1997, Pages 533-539

  Amodio, P ^a   Marchetti, P ^a   Del Piccolo, F ^a   Beghi, A ^a   Comacchio, F ^a   Carraro, P ^a   Campo, G ^a   Baruzzo, L ^a   Marchiori, C ^a   Gatta, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR BLOCKING AGENT; FLUMAZENIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; MALE; NEUROPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIME;

EID: 0030806025     PISSN: 01445979     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2281.1997.05656.x     Document Type: Article

References (30)

1. BANSKY G., MEIER P. J., ZIEGLER W. H., WALSER H., SCHMID M. & HUBER M. (1985) Reversal of hepatic coma by benzodiazepine antagonist Ro15-1788. Lancet, 1, 1324-1325.
2. BANSKY G., MEIER P. J., RIEDERER E., WALSER H., ZIEGLER W. H. & SCHMID M. (1989) Effects of the benzodiazepine receptor antagonist Flumazenil in hepatic encephalopathy in humans. Gastroenterology, 97, 44-50.
3. BASILE A. S., JONES E. A. & SKOLNICK P. (1991) The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands. Pharmacol Rev, 43, 27-71.
4. BLEY A. T. & CORDOBA J. (1996) Subclinical encephalopathy. Dig Dis, 14 (supp 1), 2-11.
5. BRUHA R., MARECEK Z., BRODANOVA M. & VOTRUBA M. (1994) Flumazenil as a diagnostic test for latent encephalopathy. J Hepatol, 20, 884.
6. BURKE D. A. (1988) Reversal of hepatic coma with Flumazenil with improvement in visual evoked potentials. Lancet, 2, 505-506.
7. CADRANEL J. F., EL YOUNSI M., PIDOUX B., ZYLBERBERG P., BENHAMOU Y., VALLA D. & OPOLON P. (1995) Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study. Eur J Gastroenterol Hepatol, 7, 325-329.
8. CONN H. O. (1977) Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Dig Dis, 22, 541-550.
9. CONN H. O., LEEVY C. M., VLAHCEVIC Z. R., RODGERS J. B., MADDREY W. C., SEEFF L. & LEVY L. L. (1977) Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. Gastroenterology, 72, 573-583.
10. FERENCI P., GRIMM G., MERYN S. & GANGL A. (1989) Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist Flumazenil. Gastroenterology, 96, 240-243.
11. FRANCO G., POIRRIER R., ETIENNE M., PIROTTE J., DAMAS P., KLEIN J. M., BELAICHE J. & FRANCK G. (1990) Reversibility of clinical and cartographic EEG abnormalities with Flumazenil in a case of hepatic encephalopathy. Therapie, 45, 289.
12. GITLIN N. (1988) Subclinical portal - systemic encephalopathy. Am J Gastrenterol, 83, 8-11.
13. GOODAY R., HAYES P. C., BZEIZI K. & O'CARROLL R. E. (1995) Benzodiazepine antagonism improves reaction time in latent hepatic encephalopathy. Psychopharmacology, 119, 295-298.
14. GRIMM G., KATZENSCHLAGER R., SCHNEEWEISS B., LENZ K., FERENCI P., MADL C., LAGGNER A. N. & GANGL A. (1988) Improvement of hepatic encephalopathy treated with Flumazenil. Lancet, 2, 1392-1394.
15. GROENEWEG M., GYR K., AMREIN R., SCOLLO-LAVIZZARI G., WILLIAMS R., YOO J. Y. & SCHALM S. W. (1996) Effect of Flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double-blind, randomised, placebo-controlled multicentre trial. Electroenceph Clin Neurophysiol, 98, 29-34.
16. GYR K., MEIER R., HÄUSSLER J., BOULÉTREAU P., FLEIG W. E., GATTA A., HOLSTEGE A., POMIER-LAYRARGUES G., SCHALM S. W., GROENWEG M., SCOLLO-LAVIZZARI G., VENTURA E., ZENEROLI M. L., WILLIAMS R., YOO Y. & AMREIN R. (1996) Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study. Gut, 39, 319-324.
17. MCCREA M., CORDOBA J., VESSEY G., BLEY A. T. & RANDOLPH C. (1996) Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol, 53, 758-63.
18. MARTINI A., COMACCHIO F. & MAGNAVITA V. (1991) Auditory evoked potentials (ABR MLR, SVR) and brain mapping in the elderly. Acta Otolaryngol, S, 476, 97-104.
19. MEHNDIRATTA M. M., SOOD G. K., SARIN S. K. & GUPTA M. (1990) Comparative evaluation of visual, somatosensory, and auditory evoked potentials in the detection of subclinical hepatic encephalopathy in patients with nonalcoholic cirrhosis. Am J Gastroenterol, 85, 799-803.
20. MOSS H. B., TARTER R., YAO J. K. & VAN THIEL D. H. (1992) Subclinical hepatic encephalopathy: relationship between neuropsychological deficits and standard laboratory tests assessing hepatic status. Arch Clin Neuropsycol, 7, 419-29.
21. PIDOUX B., ZYLBERBERG P., VALLA D. & OPOLON P. (1989) Etude électroencéphalographyque de l'effect d'un antagoniste des benzodiazépines dans l'encéphalopathie hépatique. Neurophysiol Clin, 19, 469-476.
22. POMIER-LAYRARGUES G., GIGUÈRE J. F., LAVOIE J., PERNEY P., GAGNON S., D'AMOUR M., WELLS J. & BUTTERWORTH R. F. (1994) Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind Placebo-controlled crossover trial. Hepatology, 19, 32-37.
23. PORJESZ B. & BEGLEITER H. (1987) Evoked brain potentials and alcoholism. In: Neuropsychology of Alcoholism: Implications for Diagnosis and Treatment (eds Parsons, O. A, Butters N. & Nathan, P. E.), pp. 45-63. The Guilford press, New York, London.
24. QUERO J. C., HARTMANN I. J. C., MEULSTEE J., HOP W. C. J. & SCHALM S. W. (1996) The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. J Hepatol, 24, 556-560.
25. SCOLLO-LAVIZZARI G. & STEINMANN E. (1985) Reversal of hepatic coma by benzodiazepine antagonist Ro15-1788. lancet, 1, 1324.
26. SOOD G. K., SARIN S. K., MAHAPTRA J. & BROOR S. L. (1989) Comparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: search for a rational approach. Am. J. Gastroenterol. 84, 156-159.
27. VAN DER RIJT C. C. D. & SCHALM S. W. (1992) Quantitative EEG analysis and evoked potentials to measure latent hepatic encephalopathy. J Hepatol, 14, 141-142.
28. VAN DER RIJT C. C. D., SCHALM S. W., MEULSTEE J. & STIJNEN T. (1995) Flumazenil therapy for hepatic encephalopathy. Gastroenterol Clin Biol, 19, 572-580.
29. VIEL E., DE LA COUSSAYE J. E., BASSOUL B., SAISSI G. & ELEDJAM J. J. (1990) Traitement de l'encéphalopathie hépatique aigue par le flumazénil. Ann Fr Anesth Réanim, 9, 386-389.
30. WEISSENBORN K., SCHOLZ M., HINRICHS H., WILTFANG J., SCHMIDT F. W. & KÜNKEL H. (1990) Neuropsycological assessment of early hepatic encephalopathy. Electroenceph Clin Neurophysiol, 75, 289-95.